T0	Outcomes 290 308	cell proliferation
T1	Outcomes 313 322	survival.
T2	Outcomes 397 405	efficacy
T3	Outcomes 410 416	safety
T4	Outcomes 1226 1258	median progression-free survival
T5	Outcomes 1309 1325	overall survival
T6	Outcomes 1537 1569	Median progression-free survival
T7	Outcomes 1741 1742	.
T8	Outcomes 1743 1759	However, overall
T9	Outcomes 1978 2013	grade 3 or higher adverse event was
T10	Outcomes 2112 2126	placebo group.
T11	Outcomes 2127 2141	Hyperglycaemia
T12	Outcomes 2283 2297	placebo group.
T13	Outcomes 2298 2313	Serious adverse
T14	Outcomes 2602 2617	did not improve